{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:25:24Z","timestamp":1791300324195,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,3,23]],"date-time":"2007-03-23T00:00:00Z","timestamp":1174608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Oncolytic viruses are attractive biological agents for the control of human malignancy. This study assessed the capacity of Coxsackievirus A21 (CVA21) to target and destroy multiple myeloma (MM) and precursor aberrant plasma cells <jats:italic>in vitro<\/jats:italic> using established MM cell lines and 15 patient bone marrow (BM) biopsies [<jats:italic>n<\/jats:italic>\u2003=\u200310 MM and five monoclonal gammopathy of undetermined significance (MGUS)]. Cell surface analysis revealed that all tumour cells lines expressed high levels of intercellular adhesion molecule\u20101 (ICAM\u20101) and decay\u2010accelerating factor (DAF), the receptor molecules to which CVA21 can bind, leading to subsequent cell\u2010entry and infection. MM cell lines were remarkably susceptible to CVA21 lytic infection, producing 100\u20131000\u2010fold increases in viral progeny within 24\u2003h. In contrast, normal peripheral blood cells were refractile to CVA21 infection. Furthermore, challenge of patient BM biopsies with CVA21 for 48\u2003h resulted in specific purging of up to 98\u00b77% of CD138<jats:sup>+<\/jats:sup> plasma cells, with no significant decrease in progenitor cell function. Data generated in this study suggests that CVA21 virotherapy may have potential applications as a systemic anti\u2010tumour agent for MM, or in the <jats:italic>ex vivo<\/jats:italic> purging of malignant plasma cells prior to autologous stem cell transplantation.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06550.x","type":"journal-article","created":{"date-parts":[[2007,3,23]],"date-time":"2007-03-23T15:21:12Z","timestamp":1174663272000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma"],"prefix":"10.1111","volume":"137","author":[{"given":"Gough G.","family":"Au","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.","family":"Lincz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Enno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Shafren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,23]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0503"},{"key":"e_1_2_6_3_1","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley M.C.","year":"1988","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_1","unstructured":"Anderson K.C. Kyle R.A. Berenson J.R.&Dalton W.S.(1998)Recent advances in the biology and treatment of multiple myeloma pp.63\u201388.The American Society of Haematology Education Program Washington DC."},{"key":"e_1_2_6_5_1","first-page":"1471","article-title":"Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21","volume":"26","author":"Au G.G.","year":"2005","journal-title":"International Journal of Oncology"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90207-S"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3746"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.3"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200360200"},{"key":"e_1_2_6_11_1","first-page":"610","article-title":"Anti\u2010CD54 (ICAM\u20101) has antitumor activity in SCID mice with human myeloma cells","volume":"55","author":"Huang Y.W.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_6_12_1","first-page":"657","volume-title":"Virus Taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses","author":"King A.M.Q.","year":"2000"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206315"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2004.15.821"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700733"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03102.x"},{"key":"e_1_2_6_18_1","first-page":"723","volume-title":"Fields Virology","author":"Pallansch M.A.","year":"2001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1750"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2002"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2195"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4743-3_7"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199907000-00013"},{"key":"e_1_2_6_24_1","first-page":"609","volume-title":"Fields Virology","author":"Rueckert R.R.","year":"1996"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/jvi.71.1.785-789.1997","article-title":"Mouse cells expressing human intercellular adhesion molecule\u20101 are susceptible to infection by Coxsackievirus A21","volume":"71","author":"Shafren D.R.","year":"1997","journal-title":"Journal of Virology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1128\/jvi.71.6.4736-4743.1997","article-title":"Coxsackievirus A21 binds to decay\u2010accelerating factor but requires intercellular adhesion molecule 1 for cell entry","volume":"71","author":"Shafren D.R.","year":"1997","journal-title":"Journal of Virology"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0690-3"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00202069"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2508"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309145751"},{"key":"e_1_2_6_31_1","first-page":"1317","article-title":"Validation and analysis of a mathematical model of a replication\u2010competent oncolytic virus for cancer treatment: implications for virus design and delivery","volume":"63","author":"Wein L.M.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_6_32_1","first-page":"3501","article-title":"Viruses as antitumor weapons: defining conditions for tumor remission","volume":"61","author":"Wodarz D.","year":"2001","journal-title":"Cancer Research"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06550.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06550.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:02:29Z","timestamp":1697439749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06550.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,23]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06550.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06550.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,23]]},"assertion":[{"value":"2007-03-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}